Publications Office of the EU
E-Madrid: Pharmaceutical products - EU tenders
DisplayCustomHeader
MyPortal
Language Selector
English
BasketSummary
Procurement Detail Actions Portlet

Utilities

Procurement Detail Actions Portlet
OP Portal - Procurement - Details

E-Madrid: Pharmaceutical products

Overview
  • Published
    23/06/2012
  • Deadline
    07/09/2012
  • Opening of tenders
    25/09/2012
  • Awarded
    26/10/2012
  • Today
    15/07/2026
Status
Awarded
Type of contract
Supplies
Subject for Renewal
No
Buyer
Servicio Madrileño de Salud-SUMMA 112
Place of performance
NUTS code: Multiple place of performance
Location of buyer
NUTS code: Not available
Business sector (Main CPV)
33600000 Pharmaceutical products
Total estimated contract value (excluding VAT)
993,192.60 EUR
Total final contract value (excluding VAT)
307,631.49 EUR
Procedure details
Tender reference number
PA/SU/02/12
Description

Adquisición de medicamentos antibióticos, anticoagulantes y antiinflamatorios con destino a las Unidades Asistenciales adscritas a la Gerencia del SUMMA 112.

Submission Method
Not available
Tenders may be submitted
Submission for all lots
Information about a public contract, a framework agreement or a dynamic purchasing system (DPS)
The notice involves a public contract
Conditions for opening tenders (date)
25/09/2012 13:00
Place of performance
ES30 Comunidad de Madrid
ES España
CPV code

33600000 - Pharmaceutical products

Award method
Lowest price
Estimated value
993,192.60 EUR
Final contracted value
307,631.49 EUR
Award of contract
Official name: Glaxosmithkline, S.A.
Postal address:
Town:
Postal code:
Country:
Documents
Prior information
Contract
Award
Footnote - legal notice

This content published on this page is meant purely as an additional service and has no legal effect. The Union's institutions do not assume any liability for its contents. The official versions of the relevant tendering notices are those published in the Supplement of Official Journal of the European Union and available in TED. Those official texts are directly accessible through the links embedded in this page. For more information please see Public Procurement Explainability and Liability notice.